CTSB and Parkinson disease: This study also evaluated whether APPs were elevated in three other neurodegenerative diseases, Alzheimer’s Disease (AD), frontotemperal dementia (FTD) and Parkinson’s Disease (PD), and one autoimmune neurological disorder, chronic inflammatory demyelinating polyneuropathy (CIDP).